Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.
Gynecol. Oncol., Jul;126(1):58-63 (2012)
The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
Gynecol. Oncol., Jun;125(3):531-5 (2012)
Reproductive outcomes of patients undergoing radical trachelectomy for early-stage cervical cancer.
Gynecol. Oncol., Jun;125(3):585-8 (2012)
External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer.
Gynecol. Oncol., Jun;125(3):526-30 (2012)
A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery.
Gynecol. Oncol., Aug (2012)
Risk factors for recurrence of ovarian borderline tumors.
Gynecol. Oncol., Mar;120(3):480-4 (2011)
Fertility considerations in the management of gynecologic malignancies.
Gynecol. Oncol., Mar;120(3):326-33 (2011)
Pathologic analysis of ex vivo plasma energy tumor destruction in patients with ovarian or peritoneal cancer.
Int. J. Gynecol. Cancer., Nov;20(8):1326-30 (2010)
Recovery issues of fertility-preserving surgery in patients with early-stage cervical cancer and a model for survivorship: the physician checklist.
Int. J. Gynecol. Cancer., Jan;21(1):106-16 (2011)
Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.
Gynecol. Oncol., Mar;120(3):347-52 (2011)
The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?
Int. J. Gynecol. Cancer., Apr;21(3):511-6 (2011)
Sentinel lymph node mapping for endometrial cancer improves the detection of metastatic disease to regional lymph nodes.
Gynecol. Oncol., Aug;122(2):251-4 (2011)
Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer.
Gynecol. Oncol., Aug;122(2):275-80 (2011)
Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.
Gynecol. Oncol., Oct;123(1):88-94 (2011)
A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.
Cancer., Feb;118(3):660-9 (2012)
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
Gynecol. Oncol., Jan;124(1):10-4 (2012)
Accuracy of frozen section diagnosis of ovarian borderline tumor.
Gynecol. Oncol., Dec;123(3):517-21 (2011)
Pelvic exenteration with curative intent for recurrent uterine malignancies.
Gynecol. Oncol., Jan;124(1):42-7 (2012)
Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.
Gynecol. Oncol., Apr;125(1):99-102 (2012)
The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.
Gynecol. Oncol., Nov;115(2):236-8 (2009)